{"id":716395,"date":"2022-12-02T17:08:22","date_gmt":"2022-12-02T22:08:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/"},"modified":"2022-12-02T17:08:22","modified_gmt":"2022-12-02T22:08:22","slug":"molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/","title":{"rendered":"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">AUSTIN, Texas, Dec.  02, 2022  (GLOBE NEWSWIRE) &#8212; Molecular Templates, Inc.\u00a0(Nasdaq: MTEM, \u201cMolecular Templates,\u201d or \u201cMTEM\u201d), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 \u2013 December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX. Molecular Templates will also participate in one-on-one meetings at the 64<sup>th<\/sup> American Society of Hematology (ASH) Annual Meeting which will take place December 10 \u2013 December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person and virtual meetings may be scheduled directly with Molecular Templates.<\/p>\n<p align=\"justify\">\n        <strong>45<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual San Antonio Breast Cancer Symposium (SABCS) <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Format: Poster presentation<\/li>\n<li style=\"text-align:justify\">Title\/Poster Number: A phase 1 study of the novel immunotoxin MT-5111 in patients with HER2+ tumors: interim results, Poster Number OT2-11-01<\/li>\n<li style=\"text-align:justify\">Time\/Date: 5:00 \u2013 6:15 PM CST, Wednesday December 7, 2022<\/li>\n<li style=\"text-align:justify\">Location: Hall 1, Henry B. Gonzalez Convention Center, San Antonio, TX and accessible via corporate website<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>64<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> American Society of Hematology (ASH) Annual Meeting <\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">Format: One-on-one meetings<\/li>\n<li style=\"text-align:justify\">Dates: December 10, 2022 \u2013 December 13, 2022<\/li>\n<li style=\"text-align:justify\">Location: Ernest N. Morial Convention Center, New Orleans, LA and Virtual<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Molecular Templates<\/strong>\n      <\/p>\n<p align=\"justify\">Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates\u2019 proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements <\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the \u201cAct\u201d).\u00a0Molecular Templates\u00a0disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act\u2019s Safe Harbor for forward-looking statements. \u00a0All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future financial position, future revenue, projected expenses, prospects, plans and objectives of management are forward-looking statements. In addition, when or if used in this press release, the words \u201cpotential,\u201d \u201cmay,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cpredict\u201d and similar expressions and their variants, as they relate to\u00a0Molecular Templates may identify forward-looking statements. Examples of such statements include, but are not limited to, statements regarding the safety or potential efficacy of Molecular Templates\u2019 drug or biologic candidates, including the anticipated benefits of MT-6402, MT-5111, MT-0169, and MT-8421 and Molecular Templates\u2019 next-generation ETBs; statements relating to the development of MT-6402, MT-5111, MT-0169, MT-8421 and next-generation ETBs; the expected timing for submitting various IND applications and conducting studies, opening sites and generating data;<\/em><br \/>\n        <em>the expected participation and presentation at upcoming conferences; the expected timing for providing updates on MT-6402, MT-5111, MT-0169, and MT-8421, as well as Molecular Templates\u2019 earlier stage pipeline of ETBs, including any pre-clinical data; and Molecular Templates\u2019 belief that its proprietary biologic drug platform technology, of ETBs, provides for a differentiated mechanism of action for cancer and other serious diseases.<\/em>\n      <\/p>\n<p align=\"justify\">\n        <em>Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors including, but not limited to, the uncertainties inherent in the preclinical and clinical development process; whether Molecular Templates\u2019 cash resources will be sufficient to fund its continuing operations for the periods and\/or trials anticipated; Molecular Templates\u2019 ability to timely enroll patients in its clinical trials; the ability of Molecular Templates\u2019 to protect its intellectual property rights; risks from global pandemics including COVID-19; and legislative, regulatory, political and economic developments, as well as those risks identified under the heading \u201cRisk Factors\u201d in Molecular Templates\u2019 filings with the SEC. There can be no assurance that any of Molecular Templates\u2019 drug or biologic candidates will be successfully developed, manufactured or commercialized, that final results of clinical trials will be supportive of regulatory approvals required to market products, or that any of the forward-looking information provided herein will be proven accurate. Any forward-looking statements contained in this press release speak only as of the date hereof, and Molecular Templates specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise.<\/em>\n      <\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Dr. Grace Kim<br \/>Head of Investor Relations <br \/>grace.kim@mtem.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTg2NmM3ODUtMThjNy00ZjU5LTkwNTUtYzVkYzM4NjU0MjdjLTEwOTY4Mjc=\/tiny\/Molecular-Templates-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) &#8212; Molecular Templates, Inc.\u00a0(Nasdaq: MTEM, \u201cMolecular Templates,\u201d or \u201cMTEM\u201d), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 \u2013 December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX. Molecular Templates will also participate in one-on-one meetings at the 64th American Society of Hematology (ASH) Annual Meeting which will take place December 10 \u2013 December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-716395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) &#8212; Molecular Templates, Inc.\u00a0(Nasdaq: MTEM, \u201cMolecular Templates,\u201d or \u201cMTEM\u201d), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 \u2013 December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX. Molecular Templates will also participate in one-on-one meetings at the 64th American Society of Hematology (ASH) Annual Meeting which will take place December 10 \u2013 December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person &hellip; Continue reading &quot;Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-02T22:08:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting\",\"datePublished\":\"2022-12-02T22:08:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/\"},\"wordCount\":759,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/\",\"name\":\"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=\",\"datePublished\":\"2022-12-02T22:08:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/","og_locale":"en_US","og_type":"article","og_title":"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting - Market Newsdesk","og_description":"AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) &#8212; Molecular Templates, Inc.\u00a0(Nasdaq: MTEM, \u201cMolecular Templates,\u201d or \u201cMTEM\u201d), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that they will present a poster on interim clinical results for the MT-5111 program at the San Antonio Breast Cancer Symposium (SABCS) which will take place December 6 \u2013 December 10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, TX. Molecular Templates will also participate in one-on-one meetings at the 64th American Society of Hematology (ASH) Annual Meeting which will take place December 10 \u2013 December 13, 2022 at the Ernest N. Morial Convention Center in New Orleans, LA. In-person &hellip; Continue reading \"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/","og_site_name":"Market Newsdesk","article_published_time":"2022-12-02T22:08:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting","datePublished":"2022-12-02T22:08:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/"},"wordCount":759,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/","name":"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=","datePublished":"2022-12-02T22:08:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwNzc3MCM1Mjk0NzQ5IzIwODUyNTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/molecular-templates-inc-to-present-interim-results-on-mt-5111-at-the-45th-annual-san-antonio-breast-cancer-symposium-sabcs-and-participate-at-the-64th-american-society-of-hematology-ash-annual-m\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/716395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=716395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/716395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=716395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=716395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=716395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}